stockrowIntegra LifeSciences Holdings Corporation (IART) vs Tandem Diabetes Care, Inc. (TNDM)
- Integra LifeSciences Holdings Corporation IART 13.55 −4.04%
- Tandem Diabetes Care, Inc. TNDM 16.98 −5.61%
Integra LifeSciences Holdings Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.3B against $1.1B — 1.1× the size. Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; Integra LifeSciences Holdings Corporation trades at 83.0×. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 6.84% against 0.84%. Integra LifeSciences Holdings Corporation has the higher net margin (0.79% vs −4.58%) and the higher return on invested capital (1.79% vs −5.35%). Across the 18 metrics below, Integra LifeSciences Holdings Corporation leads on 13 and Tandem Diabetes Care, Inc. on 5.
Valuation
Profitability
| Metric | IART | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.36% | 56.65% | 57.76% |
| Operating margin | 4.39% | (2.35%) | (15.07%) |
| Net margin | 0.79% | (4.58%) | (14.45%) |
| Free cash flow margin | 5.18% | (3.37%) | (3.88%) |
| Return on equity | 1.24% | (36.74%) | (10.35%) |
| Return on assets | 0.36% | (4.84%) | (17.26%) |
| Return on invested capital | 1.79% | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack